Cencora, Inc. (COR)
Summary
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model
Cencora (COR) is transitioning from a bulk pharmaceutical distributor to a specialty medicines infrastructure provider, targeting higher-margin, service-driven growth. Recent acquisitions of OneOncology and Retina Consultants of America are driving margin expansion, with Q2 adjusted gross profit up 15.7% and margin rising to 4.31%. Management raised FY2026 adjusted EPS guidance to $17.70–$17.90, expects $3B adjusted FCF, and targets 10–14% long-term EPS growth.
Cencora, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 15,194 | $3.31M | $4.64M | $1.33M | 40.26% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 100 | $14,960.9 | $30,526 | $15,565.1 | 104.04% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 240 | $59,623.89 | $73,262.4 | $13,638.51 | 22.87% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 1,750 | $200,166.41 | $530,372.5 | $330,206.09 | 164.97% |
| CE Curtis Ellergodt Rothschild Investment LLC | 207 | $47,165.99 | $63,188.82 | $16,022.83 | 33.97% |
Cencora, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Glen Santangelo Barclays | 25.94 | $7,669.28 | $7,838.88 | $169.6 | 2.21% |
Cencora, Inc. (COR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cencora, Inc. ever had a stock split?
Cencora, Inc. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Robert Mauch CEO | NYSE Exchange | 03073E105 CUSIP |
| US Country | 51,000 Employees | 1 Jun 2026 Last Dividend | 16 Jun 2009 Last Split | 4 Apr 1995 IPO Date |
Overview
Cencora, Inc., previously known as AmerisourceBergen Corporation, is a global leader in healthcare solutions, with a focus on improving patient outcomes through the efficient distribution and commercialization of pharmaceuticals and healthcare-related products. Established in 2001 and headquartered in Conshohocken, Pennsylvania, Cencora has expanded its reach by providing a wide range of services to various healthcare providers, including acute care hospitals, retail pharmacies, mail order pharmacies, and specialists across numerous disease states. The company's commitment to offering comprehensive supply chain management services, specialized software, and consulting services underscores its integral role in the healthcare sector. Through its U.S. Healthcare Solutions and International Healthcare Solutions segments, Cencora, Inc. addresses the nuanced needs of its global client base, delivering tailored services that encompass distribution, commercialization, logistics, and much more.
Products and Services
- Pharmaceutical Distribution - Cencora's core service involves the distribution of pharmaceuticals, including over-the-counter healthcare products, home healthcare supplies and equipment, to a wide range of healthcare providers like hospitals, pharmacies, and clinics. This ensures that essential medicines and healthcare supplies reach those in need efficiently.
- Pharmacy Management and Consulting Services - Offering pharmacy management, staffing, and consulting services, Cencora supports retail and institutional healthcare providers in optimizing their operations for better service delivery and improved patient care.
- Supply Management Software - The company provides advanced supply management software solutions that help healthcare providers streamline their operational processes, ensuring that they can focus on patient care without worrying about inventory and supply chain issues.
- Packaging Solutions - Tailored packaging solutions are offered to healthcare providers, facilitating the safe and reliable distribution of pharmaceuticals and healthcare products.
- Clinical Trial Support - Supporting biotechnology and pharmaceutical manufacturers with clinical trial support, product post-approval, and commercialization support services, Cencora plays a crucial role in bringing new treatments to market.
- Data Analytics and Research Services - By providing comprehensive data analytics, outcomes research services, and additional support services, Cencora aids manufacturers and healthcare providers in understanding market trends, patient outcomes, and more, enhancing healthcare delivery.
- Animal Health Products - The company also caters to the companion animal and production animal markets, offering pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients, supporting veterinary care providers in maintaining animal health.
- Specialty Products Distribution - Includes the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and specialty products to healthcare providers specializing in various disease states, including oncology.
- International Healthcare Solutions - Through its international segment, Cencora offers pharmaceutical wholesale, related services, and global commercialization services, emphasizing its role in the international healthcare supply chain. This also includes specialty transportation and logistics services for the biopharmaceutical industry, reflecting the company’s adaptability to the unique needs of global markets.
